Loading people...
Charlie Falcone is a General Partner at HC9 Ventures, an early-stage venture capital firm based in New York. Before co-founding HC9 Ventures alongside partners Richard Lungen and Jon Gordon, he served as an executive at the healthcare advisory firm Leverage Health and held earlier investment and strategy positions at Goldman Sachs and First Round Capital. In his current role, he co-manages a portfolio of over 20 companies and helped close the firm's $83 million debut fund in 2022, followed by a second fund exceeding $100 million in 2023. The Dartmouth College graduate recently expanded his corporate governance responsibilities by joining the board of directors for portfolio companies such as AgentSync in 2024. Falcone currently focuses on bridging traditional finance and emerging technology by backing seed-stage startups across the digital health, enterprise software, and fintech sectors.
Charlie Falcone stands as a pivotal figure in the venture capital landscape, serving as a General Partner at HC9 Ventures. With a keen eye for disruptive innovation and a passion for empowering visionary entrepreneurs, Falcone plays a crucial role in identifying and nurturing the next generation of market-leading technology companies. His strategic insights and deep industry knowledge make him an invaluable asset to both HC9 Ventures and its portfolio companies.
As a General Partner, Charlie Falcone is instrumental in shaping HC9 Ventures' investment strategy and executing its mission to back groundbreaking startups. His responsibilities encompass the entire investment lifecycle, from rigorous deal sourcing and comprehensive due diligence to active portfolio management and strategic advisory. Falcone works closely with founders, offering not just capital but also mentorship, operational guidance, and access to a vast network of industry experts, helping companies navigate challenges and accelerate growth. He is deeply involved in evaluating market trends, identifying promising sectors, and building strong relationships within the startup ecosystem.
Charlie Falcone's investment focus at HC9 Ventures is primarily centered on early-stage technology companies poised for significant impact. He is particularly interested in sectors such as enterprise SaaS, artificial intelligence, fintech, biotech, and consumer technology, always seeking solutions that address critical market needs or create entirely new categories. Falcone looks for companies with strong, resilient founding teams, defensible technology, scalable business models, and a clear path to market leadership. His approach is sector-agnostic within technology, driven by the potential for innovation and long-term value creation.
Prior to his role at HC9 Ventures, Charlie Falcone built a distinguished career marked by a blend of entrepreneurial experience and strategic investment acumen. His background includes significant tenures in high-growth technology companies, where he gained firsthand experience in product development, market entry, and scaling operations. This operational foundation provides him with a unique perspective, enabling him to deeply understand the challenges and opportunities faced by early-stage founders. Falcone's career also involved roles in strategic finance and corporate development, honing his analytical skills and ability to identify compelling investment opportunities across diverse industries. His journey reflects a consistent commitment to fostering innovation and driving technological advancement.
Charlie Falcone's investment philosophy extends beyond mere capital deployment. He believes in forging strong partnerships with founders, acting as a trusted advisor who provides strategic guidance through critical growth phases. While specific notable investments are proprietary to HC9 Ventures' portfolio, Falcone has been instrumental in backing numerous successful ventures that have gone on to achieve significant milestones and market recognition. His contributions have helped these companies secure follow-on funding, expand their market reach, and build robust teams, ultimately contributing to their long-term success and impact within their respective industries.
Charlie Falcone's dedication to innovation, combined with his extensive experience and strategic vision, positions him as a leading General Partner at HC9 Ventures. He continues to be a driving force in identifying and nurturing the next wave of transformative technology companies, solidifying HC9 Ventures' reputation as a premier early-stage investor.
Charlie Falcone primarily invests in early-stage technology companies across various sectors, including enterprise SaaS, artificial intelligence, fintech, biotech, and consumer technology, focusing on disruptive solutions and strong founding teams.
Charlie Falcone works as a General Partner at HC9 Ventures, a venture capital firm.